{"disease":{"id":"complete-response","name":"complete response"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03522246","title":"A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1097,"lead_sponsor_name":"pharmaand GmbH","has_results":true},{"nct_id":"NCT06755567","title":"Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":750,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06630481","title":"Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade","phase":"","overall_status":"COMPLETED","enrollment_count":462,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT01844986","title":"Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07181850","title":"Predicting Pathological Complete Response in Esophageal Squamous Cell Carcinoma Using a Multimodal Model Integrating Clinical, Radiomics, and Deep Learning Features","phase":"","overall_status":"COMPLETED","enrollment_count":363,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT01874353","title":"Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":327,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07509632","title":"Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":320,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06182657","title":"The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT07088354","title":"Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT02800317","title":"RISAS Procedure in Node Positive Breast Cancer Following NAC","phase":"NA","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT03038256","title":"Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":244,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03534453","title":"Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06854107","title":"Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Zilong Yuan","has_results":false},{"nct_id":"NCT06811844","title":"Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":208,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT03349177","title":"Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Zhiyong Yu","has_results":false},{"nct_id":"NCT06794099","title":"Study on the Applicability of CCR Criteria in Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT06364371","title":"Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":106,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05925751","title":"Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT04232423","title":"Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT04815694","title":"THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07500129","title":"Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Atlas University","has_results":false},{"nct_id":"NCT04293796","title":"Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"N.N. Petrov National Medical Research Center of Oncology","has_results":false},{"nct_id":"NCT07127497","title":"Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Anhui Medical University","has_results":false},{"nct_id":"NCT04848454","title":"Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT05563012","title":"Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false},{"nct_id":"NCT07430579","title":"Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"The Second Hospital of Shandong University","has_results":false},{"nct_id":"NCT06477991","title":"The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.","phase":"","overall_status":"RECRUITING","enrollment_count":22,"lead_sponsor_name":"Yunnan Cancer Hospital","has_results":false},{"nct_id":"NCT05822050","title":"An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT07329621","title":"A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT07006012","title":"RGL-305+ Lymphoma + Exploratory Clinical Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05503108","title":"Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer","phase":"PHASE3","overall_status":"SUSPENDED","enrollment_count":10,"lead_sponsor_name":"Leiden University Medical Center","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}